Kenvue Inc. (KVUE) is held by 8 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 5 funds adding and 2 funds trimming or exiting versus the previous quarter. 1 member of Congress reported 1 purchase vs 2 sales.
Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.
Independent Franchise Partners · Yacktman Asset Management · Saturna Capital — 8 tracked funds hold KVUE. See all holders.
1 member of Congress reported buying (1 purchase vs 2 sales). Latest buy: Jun 16, 2026. Politician trading
Fox Corp (FOX) · NEWS CORP (NWSA) · BARRICK MINING CORP (B) · EMERSON ELECTRIC CO (EMR) · NOVARTIS AG (NVS) — stocks the same funds also hold. See all related stocks.
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Independent Franchise Partners | 6.32% | 50,427,994 | ADDED (+2.5%) Q3 filed Nov 13 |
| Yacktman Asset Management | 1.90% | 8,051,004 | ADDED (+1.5%) Q3 filed Nov 2 |
| Saturna Capital | 0.39% | 1,679,259 | ADDED (+0.1%) Q3 filed Nov 16 |
| Skye Global Management | 0.17% | 456,000 | TRIMMED (-42.4%) Q3 filed Nov 16 |
| Tweedy Browne | 0.11% | 72,949 | ADDED (+78.3%) Q3 filed Nov 4 |
| Aequim Alternative Investments | 0.06% | 200,000 | HELD Q3 filed Nov 12 |
| Maverick Capital | 0.03% | 173,991 | ADDED (+89.1%) Q3 filed Nov 16 |
| Mondrian Investment Partners | 0.02% | 75,247 | TRIMMED (-98.7%) Q3 filed Oct 23 |
Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.
Price change since quarter-end: -0.1% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Oct 30, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Closing prices (unadjusted for dividends), last 2 years — 499 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.
| Institutions holding | 1,001 of 8,857 filers |
| Long-only filers among them | 999 |
| Change vs 2026 Q1 | +8 net · 895 entered · 887 exited |
| Shares reported, all filers | 1,791,153,284 |
| Reported value, all filers | $33.2B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
| Exchange | NYSE |
| Industry | Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844) |
| Revenue · FY2025 | $15.1B |
| Net income · FY2025 | $1.5B |
| Total assets · FY2025 | $27.1B |
| Shares outstanding | 1,920,773,467 |
Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Jul 31, 2026.
| Shares short · Oct 15, 2026 | 55,696,920 |
| Share of shares outstanding | 2.90% |
| Days to cover | 2.71 |
Shares short at recent settlements — Jul 31, 2026: 63.3M · Aug 14, 2026: 52.8M · Aug 31, 2026: 72.1M · Sep 15, 2026: 57.6M · Sep 30, 2026: 57.7M · Oct 15, 2026: 55.7M.
Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 31, 2026.
| Shares failed to deliver · Oct 14, 2026 | 0 |
| Share of shares outstanding | 0.00% |
| Fails as a share of short interest · Oct 15, 2026 | 0.0% |
Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.
Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 31, 2026.
Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.
| Filed | Seller | Role | Shares to sell | Market value | Approx. sale date | Source |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Howlett Heather | Officer | 3,700 | $67.0K | Jun 10, 2026 | SEC filing |
| May 8, 2026 | Orlando Matthew | Officer | 38,492 | $679.7K | May 8, 2026 | SEC filing |
| May 16, 2025 | Ruh Paul | Former Officer | 100,531 | $2.4M | May 16, 2025 | SEC filing |
| May 12, 2025 | Ruh Paul | Former Officer | 50,000 | $1.2M | May 12, 2025 | SEC filing |
| Mar 13, 2025 | Lawson Carlton | Officer | 17,100 | $393.9K | Mar 13, 2025 | SEC filing |
A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.
| Filed | Filer | Form | Shares | % owned | Event date | Source |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | FMR LLC | SC 13G/A | 157,051,418.71 | 8.2% | Jun 30, 2026 | SEC filing |
| May 6, 2026 | FMR LLC | SC 13G | 135,093,093.24 | 7.0% | Mar 31, 2026 | SEC filing |
| Apr 30, 2026 | Vanguard Capital Management | SC 13G | 143,924,768 | 7.5% | Mar 31, 2026 | SEC filing |
| Mar 27, 2026 | The Vanguard Group | SC 13G/A | 0 | 0.0% | Mar 13, 2026 | SEC filing |
| Feb 17, 2026 | T. Rowe Price Associates, Inc. | SC 13G/A | 19,752,028 | 1.0% | Dec 31, 2025 | SEC filing |
| Nov 14, 2025 | T. Rowe Price Associates, Inc. | SC 13G/A | 115,533,086 | 6.0% | Sep 30, 2025 | SEC filing |
| Nov 5, 2025 | FMR LLC | SC 13G/A | 90,322,373.8 | 4.7% | Sep 30, 2025 | SEC filing |
| Aug 14, 2025 | T. Rowe Price Associates, Inc. | SC 13G/A | 168,318,661 | 8.8% | Jun 30, 2025 | SEC filing |
| Aug 4, 2025 | Massachusetts Financial Services Company | SC 13G/A | 91,215,312 | 4.8% | Jun 30, 2025 | SEC filing |
| Jul 29, 2025 | The Vanguard Group | SC 13G/A | 233,245,730 | 12.1% | Jun 30, 2025 | SEC filing |
One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.
1 member of Congress reported buying (1 purchase vs 2 sales). Bought by Democrats. Latest buy: Jun 16, 2026.
Source: U.S. House Clerk and U.S. Senate eFD STOCK Act periodic transaction reports, as of Nov 16, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade.
Recent activity by member
| Member | Chamber | Party | Buys | Sells | Latest | Amount range |
|---|---|---|---|---|---|---|
| Hern, Kevin | House | R | 0 | 1 | Aug 5, 2026 | $1,001 - $15,000 |
| Cisneros, Gilbert | House | D | 1 | 1 | Jul 17, 2026 | $1,001 - $15,000 |
Member-level activity in the current window, most recent first (House data to Nov 16, 2026, Senate to Oct 1, 2026). House reports arrive as PDFs without transaction-level rows in the current corpus, so this table shows per-member totals, not individual trades; the member page lists the underlying filings. Senate rows link the same way — the member page carries the eFD filing links.
Industry: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844). No standing committee maps to this industry under the site’s jurisdiction rule — see Methodology.
Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.
Lobbying: 36 Lobbying Disclosure Act filings named this company as client, 2023–2026; most common issues: Health Issues (17), Taxation/Internal Revenue Code (13), Consumer Issues/Safety/Products (10).
Federal contracts: no obligated amounts found for this ticker (USASpending, fiscal years 2021–2026).
Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.
Politicians
· Bought by Members — Last 6 months: bought by a member of the U.S. Congress
Financial Screens
· Greenblatt Magic Formula — High earnings yield and high return on capital together
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Shareholder Yield — Cash returned through dividends and buybacks
Key figures
· Greenblatt Magic Formula — Earnings yield: 4.6% · Return on capital: 122.9% · Combined rank: 56
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.71 · Operating cash flow: $2.2B · Net income: $1.5B
· Shareholder Yield — Shareholder yield: 4.7% · of which dividends: 4.2% · of which buybacks: 0.5%
· Bought by Members — Members buying: 1 · Buy txns: 1 · Sell txns: 2 · Latest buy: Jun 16, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 1 | 0.0% | -6.7% | +4.7% | -11.5% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Also held by the tracked funds that hold KVUE — ranked by lift, the co-holding pattern described in Methodology: Fox Corp (FOX) · NEWS CORP (NWSA) · BARRICK MINING CORP (B) · EMERSON ELECTRIC CO (EMR) · NOVARTIS AG (NVS) · GSK plc (GSK) · UNILEVER PLC (UL) · CONOCOPHILLIPS (COP).
| Filed | Items | Source |
|---|---|---|
| Nov 4, 2026 | 3.03 Material Modification to Rights of Security Holders · 9.01 Financial Statements and Exhibits | SEC filing |
| Nov 2, 2026 | 1.02 Termination of a Material Definitive Agreement · 2.01 Completion of Acquisition or Disposition of Assets · 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule · 3.03 Material Modification to Rights of Security Holders · 5.01 Changes in Control of Registrant · 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · 8.01 Other Events · 9.01 Financial Statements and Exhibits | SEC filing |
| Oct 30, 2026 | 2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits | SEC filing |
Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.
Fox Corp (FOX) · Track Record: how the signals scored · Practice timing on KVUE
One email a week: the week’s new filings and research. Subscribe free
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.